Skip to main content
OpenTrials

Clinical trial condition

Prostatic Hyperplasia

Explore clinical trials studying Prostatic Hyperplasia. Study availability and eligibility vary by location and protocol.

611 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Hyperplasia trial results

Completed

Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)

NCT02637960

Conditions
Genital Diseases, Genital Diseases, Male, Lower Urinary Tract Symptoms, +8 more
Locations
  • Vantia Investigative Center Anniston, Alabama, United States
  • Vantia Investigative Center Goodyear, Arizona, United States
  • Vantia Investigative Center Lincoln, California, United States
  • Vantia Investigative Center Murrieta, California, United States
View all 48 locations
View Trial Details
Completed

Medical Therapy of Prostatic Symptoms

NCT00021814

Conditions
Genital Diseases, Genital Diseases, Male, Male Urogenital Diseases, +4 more
Locations
  • University of California La Jolla, California, United States
  • Univ of Colorado Health Sciences Center Aurora, Colorado, United States
  • Yale University New Haven, Connecticut, United States
  • Walter Reed Army Medical Center Washington D.C., District of Columbia, United States
View all 17 locations
View Trial Details
Completed

The Safety and Effectiveness of UroLift: LIFT Pivotal Study

NCT01294150

Conditions
Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • Genesis Research LLC San Diego, California, United States
  • Shahram S. Gholami MD - A Professional Corp. San Jose, California, United States
  • Urology Associates of Denver Englewood, Colorado, United States
  • Advanced Urology Institute Daytona Beach, Florida, United States
View all 19 locations
View Trial Details
Completed

Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement

NCT01294592

Conditions
Genital Diseases, Genital Diseases, Male, Male Urogenital Diseases, +3 more
Locations
  • GSK Investigational Site Aigrefeuille-sur-Maine, France
  • GSK Investigational Site Angers, France
  • GSK Investigational Site Angers, France
  • GSK Investigational Site Corsept, France
View all 80 locations
View Trial Details
Completed

Prospective Sexual Function Study for BPH Subjects

NCT01777269

Conditions
Genital Diseases, Genital Diseases, Male, Male Urogenital Diseases, +3 more
Locations
  • GSK Investigational Site Randwick, New South Wales, Australia
  • GSK Investigational Site Sydney, New South Wales, Australia
  • GSK Investigational Site Wahroonga, New South Wales, Australia
  • GSK Investigational Site Herston, Queensland, Australia
View all 67 locations
View Trial Details
Completed

A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

NCT02326454

Conditions
Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • Anniston, Alabama, United States
  • Huntsville, Alabama, United States
  • Anchorage, Alaska, United States
  • Laguna Hills, California, United States
View all 41 locations
View Trial Details

Related conditions